Advertisement
News
Subscribe to MDT Magazine News

Photos of the Day: Drug Injections via a Pill

October 1, 2014 11:43 am | by Massachusetts Institute of Technology | Comments

Researchers at MIT and Massachusetts General Hospital (MGH) have devised a novel drug capsule coated with tiny needles that can inject drugs directly into the lining of the stomach after the capsule is swallowed. When the pill reaches the desired...

TOPICS:

New Drug-Delivery Capsule May Replace Injections

October 1, 2014 11:42 am | by Anne Trafton, MIT News Office | Comments

Given a choice, most patients would prefer to take a drug orally instead of getting an injection. Unfortunately, many drugs, especially those made from large proteins, cannot be given as a pill because they get broken down in the stomach before...

TOPICS:

BU Receives NIH 'BEST' Grant to Promote Biomedical Careers Beyond Academia

October 1, 2014 11:11 am | by Boston University Medical Center | Comments

Boston University (BU) is one of seven institutions to receive the prestigious Broadening Experience in Scientific Training (BEST) award by the National Institutes of Health (NIH). The five-year, $1.8 million award will provide biomedical research...

TOPICS:
Advertisement

Hybrid 'Patch' Could Replace Transplants

October 1, 2014 11:00 am | by American Friends of Tel Aviv University | Comments

Because heart cells cannot multiply and cardiac muscles contain few stem cells, heart tissue is unable to repair itself after a heart attack. Now Tel Aviv University researchers are literally setting a new gold standard in cardiac tissue...

TOPICS:

The FDA Takes Steps to Strengthen Cybersecurity of Medical Devices

October 1, 2014 10:29 am | by FDA | Comments

To strengthen the safety of medical devices, the U.S. Food and Drug Administration today finalized recommendations to manufacturers for managing cybersecurity risks to better protect patient health and information. The final guidance, titled...

TOPICS:

CE Mark for LoneStar Heart’s Hydrogel Implant for the Treatment of Advanced Heart Failure

October 1, 2014 10:25 am | by PR Newswire | Comments

LoneStar Heart, Inc. has announced that it received the CE Mark for its Algisyl-LVR hydrogel implant, the company's lead product for the treatment of advanced heart failure (HF). Classified in Europe and in the U.S. as a medical device, Algisyl-LVR...

TOPICS:

Global Demand for Medical Disposables to Reach $245 Billion

October 1, 2014 10:02 am | by The Freedonia Group Inc. | Comments

Global demand for medical disposables is forecast to rise 6.6 percent annually to $245 billion in 2018. The strongest influence on growth will involve the upgrading and stricter enforcement of infection prevention protocols by hospitals and...

TOPICS:

Tissue Valves as Safe as Mechanical Valves in Middle-Aged Patients

October 1, 2014 9:39 am | by Mount Sinai Health System | Comments

New Icahn School of Medicine at Mount Sinai research findings published in the October 1 issue of JAMA show there was no significant difference in 15-year survival or stroke rates in patients aged between 50 and 69 years who had aortic valve...

TOPICS:
Advertisement

FDA Awards Grants to Stimulate Device Development for Rare Diseases

October 1, 2014 9:33 am | by FDA | Comments

The U.S. Food and Drug Administration today announced it has awarded 15 grants totaling more than $19 million to boost the development of medical device, drug, and biological products for patients with rare diseases, with at least a quarter...

TOPICS:

NIH Taps Lab to Develop Sophisticated Electrode Array System to Monitor Brain Activity

September 30, 2014 2:06 pm | by Lawrence Livermore National Laboratory | Comments

The National Institutes of Health (NIH) awarded Lawrence Livermore National Laboratory (LLNL) a grant today to develop an electrode array system that will enable researchers to better understand how the brain works through unprecedented...

TOPICS:

Race for Proteomics Knowledge Spurs Investment and Partnerships

September 30, 2014 1:56 pm | by Kalorama Information | Comments

Proteomics is a focus point for investment and collaboration, according to a new report from Kalorama Information.  The healthcare market research publisher said that over 100 deals had occurred in proteomics in the past two years. The activity...

TOPICS:

Homeland Security and FDA Address Medical Device Cybersecurity

September 30, 2014 11:53 am | by AAMI | Comments

The Department of Homeland Security is joining forces with the U.S. Food and Drug Administration (FDA) to tackle the issue of medical device cybersecurity—a tacit recognition of the emerging vulnerabilities associated with healthcare technology...

TOPICS:

NIH Awards Initial $46 Million for BRAIN Initiative Research

September 30, 2014 11:44 am | by National Institutes of Health | Comments

The National Institutes of Health announced today its first wave of investments totaling $46 million in fiscal year 14 funds to support the goals of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. More than...

TOPICS:

Bionic Vision Australia Successfully Completes Clinical Trial of Implant in Retinitis Pigmentosa

September 30, 2014 11:35 am | by Bionic Vision Australia | Comments

Bionic Vision Australia (BVA), a consortium of researchers working together to develop bionic eye devices to restore a sense of vision to people with profound vision loss, today announced the successful completion of the first clinical trial...

TOPICS:

Selectively Rewiring the Brain's Circuitry to Treat Depression

September 30, 2014 11:28 am | by Elsevier | Comments

On Star Trek, it is easy to take for granted the incredible ability of futuristic doctors to wave small devices over the heads of both humans and aliens, diagnose their problems through evaluating changes in brain activity or chemistry, and...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading